XML 17 R4.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Operations - USD ($)
shares in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]      
Net revenue $ 673,759,000 $ 740,840,000 $ 932,472,000
Cost of revenue 477,832,000 491,588,000 681,923,000
Gross profit 195,927,000 249,252,000 250,549,000
Operating expenses:      
Research and development 81,082,000 83,295,000 88,443,000
Sales and marketing 123,694,000 127,778,000 139,675,000
General and administrative 63,468,000 66,243,000 56,316,000
Litigation reserves, net (89,012,000) 178,000 20,000
Restructuring and other charges 4,479,000 3,962,000 4,577,000
Goodwill impairment 0 0 44,442,000
Intangibles impairment 0 1,071,000 0
Total operating expenses 183,711,000 282,527,000 333,473,000
Income (loss) from operations 12,216,000 (33,275,000) (82,924,000)
Other income, net [1] 12,672,000 14,139,000 902,000
Income (loss) before income taxes 24,888,000 (19,136,000) (82,022,000)
Provision for (benefit from) income taxes 12,525,000 85,631,000 (13,035,000)
Net income (loss) $ 12,363,000 $ (104,767,000) $ (68,987,000)
Net income (loss) per share      
Basic $ 0.43 $ (3.57) $ (2.38)
Diluted $ 0.42 $ (3.57) $ (2.38)
Weighted average shares used to compute net income (loss) per share:      
Basic 28,905 29,355 29,007
Diluted 29,683 29,355 29,007
[1] Amounts included gain/(loss), net from litigation settlement of $6.0 million for the year ended December 31, 2023, and gain/(loss), net from derivatives not designated as hedging instruments of $3.3 million, 0.3 million and $2.7 million, for the years ended December 31, 2024, 2023 and 2022, respectively.